| 1 |
中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021, 101(1): 11-51.
|
| 2 |
肺动脉高压筛查诊断与治疗专家共识[J]. 中华心血管病杂志,2007, 35(11): 979-987.
|
| 3 |
Chin KM, Gaine SP, Gerges C, et al. Treatment algorithm for pulmonary arterial hypertension[J]. Eur Respir J, 2024, 64(4): 2401325.
|
| 4 |
Boucly A, Gerges C, Savale L, et al. Pulmonary arterial hypertension[J]. Presse Med, 2023, 52(3): 104168.
|
| 5 |
Barnes PJ. Oxidative stress-based therapeutics in PAH[J]. Redox Biol, 2020, 33: 101544.
|
| 6 |
Ghofrani HA, Gomberg-Maitland M, Zhao L, et al. Mechanisms and treatment of pulmonary arterial hypertension[J]. Nat Rev Cardiol, 2025, 22(2): 105-120.
|
| 7 |
Johnson S, Sommer N, Cox-Flaherty K, et al. Pulmonary hypertension:a contemporary review[J]. Am J Respir Crit Care Med, 2023, 208(5): 528-548.
|
| 8 |
Sahay S, Chakinala MM, Kim NH, et al. Contemporary treatment of pulmonary arterial hypertension: A U.S. perspective[J]. Am J Respir Crit Care Med, 2024, 210(5): 581-592.
|
| 9 |
Mocumbi A, Humbert M, Saxena A, et al. Pulmonary hypertension[J]. Nat Rev Dis Primers, 2024, 10(1): 1.
|
| 10 |
Dixon SJ, Olzmann JA. The cell biology of ferroptosis[J]. Nat Rev Mol Cell Biol, 2024, 25(6): 424-442.
|
| 11 |
Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease[J]. Signal Transduct Target Ther, 2022, 7(1): 378.
|
| 12 |
Hassoun PM. Pulmonary arterial hypertension[J]. N Engl J Med, 2021, 385(25): 2361-2376.
|
| 13 |
Yang Y, Liang L, Pei W, et al. Interaction of ferroptosis and cuproptosis in the perspective of pulmonary hypertension[J]. Front Cardiovasc Med, 2025, 12: 1611449.
|
| 14 |
Ge Q, Zhang T, Yu J, et al. A new perspective on targeting pulmonary arterial hypertension: programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)[J]. Biomed Pharmacother, 2024, 181: 117706.
|
| 15 |
Wang E, Zhou S, Zeng D, Wang R. Molecular regulation and therapeutic implications of cell death in pulmonary hypertension[J]. Cell Death Discov, 2023, 9(1): 239.
|
| 16 |
Mura M, Cecchini MJ, Joseph M, et al. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension[J]. Respirology, 2019, 24(11): 1104-1110.
|
| 17 |
Romanoski CE, Qi X, Sangam S, et al. Transcriptomic profiles in pulmonary arterial hypertension associate with disease severity and identify novel candidate genes[J]. Pulm Circ, 2020, 10(4): 2045894020968531.
|
| 18 |
Saygin D, Tabib T, Bittar HET, et al. Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension[J]. Pulm Circ, 2020, 10(1): doi: 10.1177/2045894020908782
|
| 19 |
Luna-López R, Ruiz Martín A, Escribano Subías P. Pulmonary arterial hypertension[J]. Med Clin (Barc), 2022, 158(12): 622-629.
|
| 20 |
Boucherat O, Bonnet S, Provencher S, et al. Anti-remodeling therapies in pulmonary arterial hypertension[J]. Trends Pharmacol Sci, 2025, 46(7): 674-691.
|
| 21 |
任成山,卞士柱,胡明冬. 肺动脉高压的成因及治疗新理念[J/OL]. 中华肺部疾病杂志(电子版) 2023, 16(1): 1-5.
|
| 22 |
Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
|
| 23 |
Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications[J]. Cell, 2022, 185(14): 2401-2421.
|
| 24 |
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease[J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
|
| 25 |
Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins[J]. Science, 2022, 375(6586): 1254-1261.
|
| 26 |
Hu P, Xu Y, Jiang Y, et al. The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11[J]. Eur J Pharmacol, 2022, 928: 175093.
|
| 27 |
Mancias JD, Wang X, Gygi SP, et al. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy[J]. Nature, 2014, 509(7498): 105-109.
|
| 28 |
Ou Y, Wang SJ, Li D, et al. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses[J]. Proc Natl Acad Sci U S A, 2016, 113(44): E6806-E6812.
|